Armistice Capital, LLC Reports New 9.99% Stake in Inspira Technologies Oxy B.H.N. Ltd. (IINN)

On May 15, 2026, Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G disclosing a new significant ownership stake in Inspira Technologies Oxy B.H.N. Ltd. (IINN). As of the event date on March 31, 2026, the reporting persons beneficially own 4,343,252 ordinary shares, representing a 9.99% ownership interest in the company. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital, LLC serves as the investment manager. By virtue of this relationship, Armistice Capital and Mr. Boyd share voting and dispositive power over the reported securities. The filing indicates that the acquisition was made in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This filing marks a substantial increase from a previously reported 0% position, establishing Armistice Capital as a major institutional shareholder in the Israel-based medical technology company.